6 chapters across the catalog
The concept of "newgenics" is introduced, where globalization and corporate profit—rather than national flags—determine who is "fit." The hosts discuss "gene lining" (genetic discrimination) and the potential for mRNA vaccines to alter DNA, citing Dr. Peter McCullough. They warn that the "white coats" of the 21st century are the new "white hoods" of systemic control.
Dr. Fauci appears on MSNBC with Rachel Maddow to discuss how mRNA technology perfected during the COVID-19 pandemic is being applied to HIV research. He claims that the investment in basic biomedical research has resulted in saving millions of lives. The hosts compare the efficacy rates of early HIV trials to the declining efficacy of modern vaccines.
A listener named Jacob Smith shares a story of being disowned from family gatherings for refusing the COVID-19 vaccine after already having a mild case of the virus. Adam Curry shares a similar experience with his own family in Holland. The hosts characterize the demand for total compliance as "cult behavior" that ignores natural immunity and individual choice.
Dr. Kizzmekia "Kizzy" Corbett, a lead scientist in the development of the Moderna vaccine, addresses concerns about mRNA technology and its impact on human genes and fertility. She and Dr. Fauci assert that mRNA does not alter DNA or genetic makeup. The hosts question the lack of long-term studies to support these definitive claims, particularly regarding reproductive health.
Jennifer Kahn's TED talk on gene drives is used to illustrate how the technology could be used to eliminate "invasive species" by ensuring only male offspring are born. The hosts warn that humans could be labeled as an "invasive species" by those in power. They argue that the lack of informed consent regarding mRNA and gene-editing technology is a "disingenuous" word game played by the scientific community.
Dr. Kizmika Corbett of the NIAID explains the mechanics of the mRNA vaccine developed in collaboration with Moderna, which uses genetic material to encode the coronavirus spike protein. The NIAID reportedly owns a significant portion of the patents for this technology, which is being fast-tracked through the regulatory process. The delivery mechanism is described as a "Trojan horse" that recodes cells to produce an immune response.
